Volume 7, 2021
Special Issue: "SICOT Education Academy Collection" Guest Editor: H. Said
Article Number 61
Number of page(s) 10
Section Hip
Published online 30 November 2021
  1. Knight SR, Aujla R, Biswas SP (2011) Total Hip Arthroplasty – over 100 years of operative history. Orthop Rev (Pavia) 3, 16. [CrossRef] [Google Scholar]
  2. Ben-Shlomo Y, Blom A, Boulton C, Brittain R, Clark E, Craig R, Dawson-Bowling S, Deere K, Esler C, Espinoza O, Goldberg A, Gregson C, Howard P, Hunt Jameson LS, Jennison T, Judge A, Lawrence S, Lenguerrand E, McCormack V, Newell C, Porteous M, Price A, Prieto-Alhambra D, Reed M, Rees J, Royall M, Sayers A, Stonadge J, Swanson M, Taylor D, Toms A, Watts A, Whitehouse M, Wilkinson M, Wilton T, Young E (2020) The National Joint Registry 17th Annual Report 2020. London: National Joint Registry. [Google Scholar]
  3. Sloan M, Premkumar A, Sheth NP (2018) Projected volume of primary total joint arthroplasty in the US, 2014 to 2030. J Bone Jt Surg Am 100, 1455–1460. [CrossRef] [PubMed] [Google Scholar]
  4. Januel JM, Chen G, Ruffieux C, Quan H, Douketis JD, Crowther MA, Colin C, Ghali WA, Burnand B (2012) Symptomatic in-hospital deep vein thrombosis and pulmonary embolism following hip and knee arthroplasty among patients receiving recommended prophylaxis: A systematic review. JAMA 307, 294–303. [CrossRef] [PubMed] [Google Scholar]
  5. Parvizi J, Huang R, Raphael IJ, Arnold WV, Rothman RH (2014) Symptomatic pulmonary embolus after joint arthroplasty: Stratification of risk factors. Clin Orthop Relat Res 472, 903–912. [CrossRef] [PubMed] [Google Scholar]
  6. Ahmed SS, Haddad FS (2019) Prosthetic joint infection. Bone Jt Res 8, 570–572. [CrossRef] [Google Scholar]
  7. Complications of total hip arthroplasty – UpToDate. Accessed 20 Apr 2021. [Google Scholar]
  8. Della Rocca GJ, Leung KS, Pape HC (2011) Periprosthetic fractures: epidemiology and future projections. J Orthop Trauma 25, S66–S70. [CrossRef] [PubMed] [Google Scholar]
  9. Desai AS, Dramis A, Board TN (2013) Leg length discrepancy after total hip arthroplasty: a review of literature. Curr Rev Musculoskelet Med 6, 336–341. [CrossRef] [PubMed] [Google Scholar]
  10. Khan M, Della Valle CJ, Jacofsky DJ, Meneghini RM, Haddad FS (2015) Early postoperative complications after total hip arthroplasty: current strategies for prevention and treatment. Instr Course Lect 64, 337–346. [PubMed] [Google Scholar]
  11. Gurney B, Mermier C, Robergs R, Gibson A, Rivero D (2001) Effects of limb-length discrepancy on gait economy and lower-extremity muscle activity in older adults. J Bone Jt Surg Ser A 83, 907–915. [CrossRef] [PubMed] [Google Scholar]
  12. Fleischman AN, Tarabichi M, Magner Z, Parvizi J, Rothman RH (2019) Mechanical complications following total hip arthroplasty based on surgical approach: a large, Single-Institution Cohort Study. J Arthroplasty 34, 1255–1260. [CrossRef] [PubMed] [Google Scholar]
  13. White RE, Forness TJ, Allman JK, Junick DW (2001) Effect of posterior capsular repair on early dislocation in primary total hip replacement. Clin Orthop Relat Res 393, 163–167. [CrossRef] [Google Scholar]
  14. Binns M, Pho R (1990) Femoral vein occlusion during hip arthroplasty. Clin Orthop Relat Res 255, 168–172. [Google Scholar]
  15. Huo MH, Salvati EA, Sharrock NE, Brien WW, Sculco TP, Pellicci PM, Mineo R, Go G (1992) Intraoperative heparin thromboembolic prophylaxis in primary total hip arthroplasty. A prospective, randomized, controlled, clinical trial. Clin Orthop Relat Res 274, 35–46. [Google Scholar]
  16. Sharrock NE, Go G, Harpel PC, Ranawat CS, Sculco TP, Salvati EA (1995) The John Charnley Award. Thrombogenesis during total hip arthroplasty. Clin Orthop Relat Res (319), 16–27. [PubMed] [Google Scholar]
  17. Newman JM, Abola MV, Macpherson A, Klika AK, Barsoum WK, Higuera CA (2017) ABO blood group is a predictor for the development of venous thromboembolism after total joint arthroplasty. J Arthroplasty 32, S254–S258. [CrossRef] [PubMed] [Google Scholar]
  18. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW (2008) Prevention of venous thromboembolism. Chest 133, 381S–453S. [CrossRef] [PubMed] [Google Scholar]
  19. Gonzalez Della Valle A, Shanaghan KA, Nguyen J, Liu J, Memtsoudis S, Sharrock NE, Salvati EA (2020) Multimodal prophylaxis in patients with a history of venous thromboembolism undergoing primary elective hip arthroplasty. Bone Joint J 102-B, 71–77. [CrossRef] [PubMed] [Google Scholar]
  20. Wilson JM, Farley KX, Bradbury TL, Guild GN (2020) Is spinal anesthesia safer than general anesthesia for patients undergoing revision THA? Analysis of the ACS-NSQIP Database. Clin Orthop Relat Res 478, 80–87. [CrossRef] [PubMed] [Google Scholar]
  21. Hines JT, Hernandez NM, Amundson AW, Pagnano MW, Sierra RJ, Abdel MP (2019) Intravenous tranexamic acid safely and effectively reduces transfusion rates in revision total hip arthroplasty. Bone Joint J 101-B, 104–109. [CrossRef] [PubMed] [Google Scholar]
  22. Fígar A, Mc Loughlin S, Slullitel PA, Scordo W, Buttaro MA (2017) Influence of single-dose intravenous tranexamic acid on total hip replacement: A study on transfusions, collateral complications, and readmissions. Orthopade 46, 359–365. [CrossRef] [PubMed] [Google Scholar]
  23. Mariani P, Buttaro MA, Slullitel PA, Comba FM, Zanotti G, Ali P, Piccaluga F (2018) Transfusion rate using intravenous tranexamic acid in hip revision surgery. HIP Int, 28, 194–199. [CrossRef] [PubMed] [Google Scholar]
  24. Clavé A, Gérard R, Lacroix J, Baynat C, Danguy des Déserts M, Gatineau F, Mottier D. 2019. A randomized, double-blind, placebo-controlled trial on the efficacy of tranexamic acid combined with rivaroxaban thromboprophylaxis in reducing blood loss after primary cementless total hip arthroplasty. Bone Joint J 101-B 207–212. [CrossRef] [PubMed] [Google Scholar]
  25. Gonzalez Della Valle A, Shanaghan KA, Nguyen J, Liu J, Memtsoudis S, Sharrock NE, Salvati EA (2020) Multimodal prophylaxis in patients with a history of venous thromboembolism undergoing primary elective hip arthroplasty. Bone Joint J 102-B 71–77. [CrossRef] [PubMed] [Google Scholar]
  26. Tompkins G, Neighorn C, Li H-F, Fleming K, Lorish T, Duwelius P, Sypher K (2020) Extremes of body mass index have significant impact on complications, readmissions, and utilization of post-acute services after primary total hip arthroplasty. Bone Joint J, 102-B 62–70. [CrossRef] [PubMed] [Google Scholar]
  27. Dorr LD, Gendelman V, Maheshwari AV, Boutary M, Wan Z, Long WT (2007) Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment. J Bone Jt Surg Am 89, 2648–2657. [CrossRef] [PubMed] [Google Scholar]
  28. Nam D, Nunley RM, Johnson SR, Keeney JA, Clohisy JC, Barrack RL (2016) The effectiveness of a risk stratification protocol for thromboembolism prophylaxis after hip and knee arthroplasty. J Arthroplasty 31, 1299–1306. [CrossRef] [PubMed] [Google Scholar]
  29. Rodgers A, MacMahon S, Collins R, Prentice C (2000) Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 355, 1295–1302. [CrossRef] [PubMed] [Google Scholar]
  30. Becattini C, Agnelli G, Schenone A, Eichinger S, Bucherini E, Silingardi M, Bianchi M, Moia M, Ageno W, Vandelli MR, Grandone E, Prandoni P (2012) Aspirin for preventing the recurrence of venous thromboembolism. N Engl J Med 366, 1959–1967. [CrossRef] [PubMed] [Google Scholar]
  31. Brighton TA, Eikelboom JW, Mann K, Mister R, Gallus A, Ockelford P, Gibbs H, Hague W, Xavier D, Diaz R, Kirby A, Simes J (2012) Low-dose aspirin for preventing recurrent venous thromboembolism. N Engl J Med 367, 1979–1987. [CrossRef] [PubMed] [Google Scholar]
  32. Parvizi J, Huang R, Restrepo C, Chen AF, Austin MS, Hozack WJ, Lonner JH (2017) Low-dose aspirin is effective chemoprophylaxis against clinically important venous thromboembolism following total joint arthroplasty. J Bone Jt Surg 99, 91–98. [CrossRef] [PubMed] [Google Scholar]
  33. Anderson DR, Dunbar M, Murnaghan J, Kahn SR, Gross P, Forsythe M, Pelet S, Fisher W, Belzile E, Dolan S, Crowther M, Bohm E, MacDonald SJ, Gofton W, Kim P, Zukor D, Pleasance S, Andreou P, Doucette S, Theriault C, Abianui A, Carrier M, Kovacs MJ, Rodger MA, Coyle D, Wells PS, Vendittoli P-A (2018) Aspirin or rivaroxaban for VTE prophylaxis after hip or knee arthroplasty. N Engl J Med 378, 699–707. [CrossRef] [PubMed] [Google Scholar]
  34. Richards M, Alyousif H, Kim J-K, Poitras S, Penning J, Beaulé PE (2018) An evaluation of the safety and effectiveness of total hip arthroplasty as an outpatient procedure: a matched-Cohort analysis. J Arthroplasty 33, 3206–3210. [CrossRef] [PubMed] [Google Scholar]
  35. Eriksson BI, Dahl OE, Rosencher N, Kurth AA, van Dijk CN, Frostick SP, Prins MH, Hettiarachchi R, Hantel S, Schnee J, Büller HR (2007) Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial. Lancet 370, 949–956. [CrossRef] [PubMed] [Google Scholar]
  36. Lassen MR, Gallus A, Raskob GE, Pineo G, Chen D, Ramirez LM (2010) Apixaban versus enoxaparin for thromboprophylaxis after hip replacement. N Engl J Med 363, 2487–2498. [CrossRef] [PubMed] [Google Scholar]
  37. Hughes LD, Lum J, Mahfoud Z, Malik RA, Anand A, Charalambous CP (2020) Comparison of surgical site infection risk between warfarin, LMWH, and aspirin for venous thromboprophylaxis in TKA or THA. JBJS Rev 8(e20), 00021. [Google Scholar]
  38. Eriksson B, Dahl O, Rosencher N, Kurth A, van Dijk C, Frostick S, Prins M, Hettiarachchi R, Hantel S, Schnee J, Büller H (2007) Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial. Lancet (London, England) 370, 949–956. [CrossRef] [PubMed] [Google Scholar]
  39. Kurtz SM, Lau E, Watson H, Schmier JK, Parvizi J (2012) Economic burden of periprosthetic joint infection in the United States. J Arthroplasty 27, 61–65.e1. [CrossRef] [PubMed] [Google Scholar]
  40. Ferry T, Batailler C, Brosset S, Kolenda C, Goutelle S, Sappey-Marinier E, Josse J, Laurent F, Lustig S (2020) Medical innovations to maintain the function in patients with chronic PJI for whom explantation is not desirable: a pathophysiology-, multidisciplinary-, and experience-based approach. SICOT-J 6, 26. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  41. McConoughey SJ, Howlin R, Granger JF, Manring MM, Calhoun JH, Shirtliff M, Kathju S, Stoodley P (2014) Biofilms in periprosthetic orthopedic infections. Future Microbiol 9, 987–1007. [CrossRef] [PubMed] [Google Scholar]
  42. Aalirezaie A, Bauer TW, Fayaz H, Griffin W, Higuera CA, Krenn V, Krenn V, Molano M, Moojen DJ, Restrepo C, Shahi AS, Shubnyakov I, Sporer S, Tanavalee A, Teloken M, Velázquez Moreno JD (2019) Hip and knee section, diagnosis, reimplantation: Proceedings of International Consensus on Orthopedic Infections. J Arthroplasty 34, 369–379. [Google Scholar]
  43. Namba RS, Paxton L, Fithian DC, Stone ML (2005) Obesity and perioperative morbidity in total hip and total knee arthroplasty patients. J Arthroplasty 20, 46–50. [CrossRef] [PubMed] [Google Scholar]
  44. Arnold N, Anis H, Barsoum WK, Bloomfield MR, Brooks PJ, Higuera CA, Kamath AF, Klika A, Krebs VE, Mesko NW, Molloy RM, Mont MA, Murray TG, Patel PD, Strnad G, Stearns KL, Warren J, Ms AZ, Piuzzi NS (2020) Preoperative cut-off values for body mass index deny patients clinically significant improvements in patient-reported outcomes after total hip arthroplasty. Bone Jt J 102, 683–692. [Google Scholar]
  45. Kim C-W, Kim H-J, Lee C-R, Wang L, Rhee SJ (2020) Effect of chronic kidney disease on outcomes of total joint arthroplasty: a meta-analysis. Knee Surg Relat Res 321(32), 1–12. [Google Scholar]
  46. Bozic KJ, Lau E, Kurtz S, Ong K, Rubash H, Vail TP, Berry DJ (2012). Patient-related risk factors for periprosthetic joint infection and postoperative mortality following total hip arthroplasty in medicare patients. J Bone Jt Surg Ser A 94, 794–800. [CrossRef] [PubMed] [Google Scholar]
  47. Kaspar S, de Beer J de V (2005) Infection in hip arthroplasty after previous injection of steroid. J Bone Jt Surg Ser B 87, 454–457. [CrossRef] [Google Scholar]
  48. Danoff JR, Moss G, Liabaud B, Geller JA (2013) Total knee arthroplasty considerations in rheumatoid arthritis. Autoimmune Dis 2013, 185340. [PubMed] [Google Scholar]
  49. Jerry GJ Jr, Rand JA, Ilstrup D (1988). Old sepsis prior to total knee arthroplasty – PubMed. Clin Orthop Relat Res 236, 135–140. [Google Scholar]
  50. Bouvet C, Lübbeke A, Bandi C, Pagani L, Stern R, Hoffmeyer P, Uçkay I (2014) Is there any benefit in pre-operative urinary analysis before elective total joint replacement? Bone Joint J 96-B, 390–394. [CrossRef] [PubMed] [Google Scholar]
  51. Gonzalez A, Luime J, Uçkay I, Hannouche D, Hoffmeyer P, Lübbeke A (2018) Is there an association between smoking status and prosthetic joint infection after primary total joint arthroplasty? J Arthroplasty 33, 2218–2224. [CrossRef] [PubMed] [Google Scholar]
  52. Bojan B, Perni S, Prokopovich P (2020) Systematic review and meta-analysis of tobacco use as a risk factor for prosthetic joint infection after total hip replacement. Arthroplast Today 6, 959. [CrossRef] [PubMed] [Google Scholar]
  53. Werner BC, Cancienne JM, Browne JA (2016) The timing of total hip arthroplasty after intraarticular hip injection affects postoperative infection risk. J Arthroplasty 31, 820–823. [CrossRef] [PubMed] [Google Scholar]
  54. Slullitel PA, Oñativia JI, Zanotti G, Comba F, Piccaluga F, Buttaro MA (2021) One-stage exchange should be avoided in periprosthetic joint infection cases with massive femoral bone loss or with history of any failed revision to treat periprosthetic joint infection 103, 1247–1253. [Google Scholar]
  55. Tan TL, Xu C, Kuo F-C, Ghanem E, George J, Shohat N, Chen J-Y, Lee MS, Higuera C, Parvizi J (2021) When total joint arthroplasty after septic arthritis can be safely performed. JBJS Open Access 6, e20.00146. [Google Scholar]
  56. Demircay E, Unay K, Bilgili MG, Alataca G (2010) Glove perforation in hip and knee arthroplasty. J Orthop Sci 15, 790–794. [CrossRef] [PubMed] [Google Scholar]
  57. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR (1999) Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee – PubMed. Am J Infect Control 27, 97–132. [CrossRef] [PubMed] [Google Scholar]
  58. Nowak LL, Schemitsch EH (2019) Duration of surgery affects the risk of complications following total hip arthroplasty. Bone Joint J, 101-B, 51–56. [CrossRef] [PubMed] [Google Scholar]
  59. Anglen JO, Apostoles S, Christensen G, Gainor B (1994) The efficacy of various irrigation solutions in removing slime-producing staphylococcus. J Orthop Trauma 8, 390–396. [CrossRef] [PubMed] [Google Scholar]
  60. Wyles CC, Hevesi M, Osmon DR, Park MA, Habermann EB, Lewallen DG, Berry DJ, Sierra RJ (2019) 2019 John Charnley Award: Increased risk of prosthetic joint infection following primary total knee and hip arthroplasty with the use of alternative antibiotics to cefazolin. Bone Joint J 101-B, 9–15. [CrossRef] [PubMed] [Google Scholar]
  61. Goldstein M, Feldmann C, Wulf H, Wiesmann T (2017) Tranexamic acid prophylaxis in hip and knee joint replacement. Dtsch Arztebl Int 114, 824–830. [PubMed] [Google Scholar]
  62. Kim SM, Moon YW, Lim SJ, Kim DW, Park YS (2016) Effect of oral factor Xa inhibitor and low-molecular-weight heparin on surgical complications following total hip arthroplasty. Thromb Haemost 115, 600–607. [CrossRef] [PubMed] [Google Scholar]
  63. Parvizi J, Huang R, Restrepo C, Chen AF, Austin MS, Hozack WJ, Lonner JH (2017) Low-dose aspirin is effective chemoprophylaxis against clinically important venous thromboembolism following total joint arthroplasty a preliminary analysis. J Bone Jt Surg Am 99, 91–98. [CrossRef] [PubMed] [Google Scholar]
  64. Gibbs VN, McCulloch RA, Dhiman P, McGill A, Taylor AH, Palmer AJR, Kendrick BJL (2020) Modifiable risk factors for mortality in revision total hip arthroplasty for periprosthetic fracture. Bone Jt J 102-B, 580–585. [CrossRef] [PubMed] [Google Scholar]
  65. Sheth NP, Brown NM, Moric M, Berger RA, Della Valle CJ (2013) Operative treatment of early peri-prosthetic femur fractures following primary total hip arthroplasty. J Arthroplasty 28, 286–291. [CrossRef] [PubMed] [Google Scholar]
  66. Lindahl H (2007) Epidemiology of periprosthetic femur fracture around a total hip arthroplasty. Injury 38, 651–654. [CrossRef] [PubMed] [Google Scholar]
  67. Chatziagorou G, Lindahl H, Kärrholm J (2019) The design of the cemented stem influences the risk of Vancouver type B fractures, but not of type C: an analysis of 82,837 Lubinus SPII and Exeter Polished stems. Acta Orthop 90, 135. [CrossRef] [PubMed] [Google Scholar]
  68. Thien T, Chatziagorou G, Garellick G, Furnes O, Havelin L, Mäkelä K, Overgaard S, Pedersen A, Eskelinen A, Pulkkinen P, Kärrholm J (2014) Periprosthetic femoral fracture within two years after total hip replacement: analysis of 437,629 operations in the nordic arthroplasty register association database. J Bone Joint Surg Am 96, e167. [CrossRef] [PubMed] [Google Scholar]
  69. Palan J, Smith M, Gregg P, Mellon S, Kulkarni A, Tucker K, Blom A, Murray D, Pandit H (2016) The influence of cemented femoral stem choice on the incidence of revision for periprosthetic fracture after primary total hip arthroplasty: an analysis of National Joint Registry Data. Bone Joint J 98-B, 1347–1354. [CrossRef] [PubMed] [Google Scholar]
  70. Brodén C, Mukka S, Muren O, Eisler T, Boden H, Stark A, Sköldenberg O (2015) High risk of early periprosthetic fractures after primary hip arthroplasty in elderly patients using a cemented, tapered, polished stem. Acta Orthop 86, 169–174. [CrossRef] [PubMed] [Google Scholar]
  71. Meermans G, Konan S, Das R, Volpin A, Haddad F (2017). The direct anterior approach in total hip arthroplasty: a systematic review of the literature. Bone Joint J 99-B, 732–740. [CrossRef] [PubMed] [Google Scholar]
  72. Fontalis A, Epinette J-A, Thaler M, Zagra L, Khanduja V, Haddad FS (2021) Advances and innovations in total hip arthroplasty. SICOT-J 7, 26. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  73. Pincus D, Jenkinson R, Paterson M, Leroux T, Ravi B (2020) Association between surgical approach and major surgical complications in patients undergoing total hip arthroplasty. JAMA 323, 1070–1076. [CrossRef] [PubMed] [Google Scholar]
  74. Horberg JV, Coobs BR, Jiwanlal AK, Betzle CJ, Capps SG, Moskal JT (2021) Dislocation rates following total hip arthroplasty via the direct anterior approach in a consecutive, non-selective cohort. Bone Joint J 103B, 38–45. [CrossRef] [PubMed] [Google Scholar]
  75. Wang Z, Hou J, Wu C, Zhou Y, Gu X, Wang H, Feng W, Cheng Y, Sheng X, Bao H (2018) A systematic review and meta-analysis of direct anterior approach versus posterior approach in total hip arthroplasty. J Orthop Surg Res 13, 229. [CrossRef] [PubMed] [Google Scholar]
  76. Schloemann DT, Edelstein AI, Barrack RL (2019) Changes in acetabular orientation during total hip arthroplasty. Bone Joint J 101B, 45–50. [CrossRef] [PubMed] [Google Scholar]
  77. Vigdorchik J, Jerabek SA, Mayman DJ, Elbuluk A, Abdel MP, Buckland AJ, Schwarzkopf RS, Eftekhary N (2019) Evaluation of the spine is critical in the workup of recurrent instability after total hip arthroplasty. Bone Jt J 101-B, 817–823. [CrossRef] [PubMed] [Google Scholar]
  78. Eftekhary N, Buckland A, Schwarzkopf R, Shimmin A, Lazennec JY, Dorr LD, Mayman D, Padgett D, Vigdorchik J (2019) A systematic approach to the hip-spine relationship and its applications to total hip arthroplasty. Bone Jt J 101-B, 807–816. [Google Scholar]
  79. Ransone M, Fehring K, Fehring T (2020) Standardization of lateral pelvic radiograph is necessary to predict spinopelvic mobility accurately. Bone Joint J 102-B, 41–46. [CrossRef] [PubMed] [Google Scholar]
  80. Innmann MM, Merle C, Gotterbarm T, Ewerbeck V, Beaulé PE, Grammatopoulos G (2019) Can spinopelvic mobility be predicted in patients awaiting total hip arthroplasty? A prospective, diagnostic study of patients with end-stage hip osteoarthritis. Bone Jt J 101-B, 902–909. [CrossRef] [PubMed] [Google Scholar]
  81. Nam D, Salih R, Nahhas CR, Barrack RL, Nunley RM (2019) Is a modular dual mobility acetabulum a viable option for the young, active total hip arthroplasty patient? Bone Joint J 101-B, 365–371. [CrossRef] [PubMed] [Google Scholar]
  82. Jones CW, De Martino I, D’Apolito R, Nocon AA, Sculco PK, Sculco TP (2019) The use of dual-mobility bearings in patients at high risk of dislocation. Bone Joint J 101-B, 41–45. [CrossRef] [Google Scholar]
  83. Giacomo P, Giulia B, Valerio P, Vincenzo S, Pierluigi A (2021) Dual mobility for total hip arthroplasty revision surgery: A systematic review and metanalysis. SICOT-J 7, 18. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  84. Mononen H, Sund R, Halme J, Kröger H, Sirola J (2020) Following total hip arthroplasty: Femoral head component diameter of 32 mm or larger is associated with lower risk of dislocation in patients with a prior lumbar fusion. Bone Joint J 102-B, 1003–1009. [CrossRef] [PubMed] [Google Scholar]
  85. Kim SC, Lim YW, Kwon SY, Jo WL, Heu JY, Kim YS (2019) Effect of leg-length discrepancy following total hip arthroplasty on collapse of the contralateral hip in bilateral non-traumatic osteonecrosis of the femoral head. Bone Joint J 101-B, 303–310. [CrossRef] [PubMed] [Google Scholar]
  86. Kayani B, Konan S, Thakrar RR, Huq SS, Haddad FS. 2019. Assuring the long-term total joint arthroplasty. Bone Joint J 101-B, 11–18. [CrossRef] [PubMed] [Google Scholar]
  87. Emara AK, Zhou G, Klika AK, Koroukian SM, Schiltz NK, Higuera-Rueda CA, Molloy RM, Piuzzi NS (2021) Is there increased value in robotic arm-assisted total hip arthroplasty? Bone Joint J 103-B 1488–1496. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.